---
title: "Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290436745.md"
description: "A wearable continuous patient monitor called the Radius VSM® has received FDA 510(k) clearance for its OIRD detection feature powered by Masimo smartSET™ and enabled by artificial intelligence in Irvine, California. This approval signifies the device's capability to detect oxygen-induced respiratory depression (OIRD) effectively."
datetime: "2026-06-22T12:11:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290436745.md)
  - [en](https://longbridge.com/en/news/290436745.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290436745.md)
generator: "portal-rs"
---

# Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

A wearable continuous patient monitor called the Radius VSM® has received FDA 510(k) clearance for its OIRD detection feature powered by Masimo smartSET™ and enabled by artificial intelligence in Irvine, California. This approval signifies the device's capability to detect oxygen-induced respiratory depression (OIRD) effectively.

### Related Stocks

- [MASI.US](https://longbridge.com/en/quote/MASI.US.md)

## Related News & Research

- [Masimo wins FDA clearance for AI opioid respiratory depression detection on Radius VSM monitor](https://longbridge.com/en/news/290432032.md)
- [Walmart Shares Rise After $Billion-Scale Opioid Lawsuit Settlement](https://longbridge.com/en/news/297358654.md)
- [Why the AI boom has become an election problem](https://longbridge.com/en/news/297766132.md)
- [Mamdani is putting AI on recess for 600,000 students](https://longbridge.com/en/news/297813637.md)
- [Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands](https://longbridge.com/en/news/297404631.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**